STatin TReatment for COVID-19 to Optimise NeuroloGical recovERy (STRONGER): study protocol for a randomised, open label clinical trial in patients with persistent neurological symptoms after COVID-19 infection
Authors
Craig S. Anderson (ORCID: https://orcid.org/0000-0002-7248-4863)
Meng Law (ORCID: https://orcid.org/0000-0001-8414-1991)
STatin TReatment for COVID-19 to Optimise NeuroloGical recovERy (STRONGER): study protocol for a randomised, open label clinical trial in patients with persistent neurological symptoms after COVID-19 infection
Craig S. Anderson, Meng Law, Owen Hutchings, Carlos Delfino et al.
Citations
1 citations
Journal
BMJ Open
Topics
Long-Term Effects of COVID-19
Field-Weighted Citation Impact (FWCI)
1.39
article
STatin TReatment for COVID-19 to Optimise NeuroloGical recovERy (STRONGER): study protocol for a randomised, open label clinical trial in patients with persistent neurological symptoms after COVID-19 infection
Craig S. Anderson, Meng Law, Owen Hutchings, Carlos Delfino, Sophia Zoungas, Mark Woodward, Karin S Leder, Paula Muñoz Venturelli, Nirupama Wijesuriya, Ximena Stecher, Julian Elliott, Ian H. Harding, Xiaolei Lin, Sharon L. Naismith, Cheryl E. Carcel, Ruth Peters, Xia Wang
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 15(4)
Institutions
The University of Sydney (AU), Universidad del Desarrollo (CL), The George Institute for Global Health (GB), Fudan University (CN), Royal Prince Alfred Hospital (AU), Clínica Alemana (CL), UNSW Sydney (AU), The George Institute for Global Health (AU), Shanghai Center for Brain Science and Brain-Inspired Technology (CN), Monash University (AU)
Funders
Agencia Nacional de Investigación y Desarrollo, Medical Research Council, National Health and Medical Research Council